XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Sep. 30, 2023
Current    
Cash and cash equivalents $ 132,187 $ 151,024
Incentive and tax receivables 2,449 2,709
Prepaid expenses and other current assets 931 653
Total Assets 135,567 154,386
Current Liabilities    
Accounts payable 9,627 4,322
Accrued liabilities - Note 3 4,835 7,295
Deferred grant income - Note 4 842 917
Total Liabilities 15,304 12,534
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized: 200,000,000 common stock, par value $0.001 per Issued and outstanding: 84,795,517 common shares (2023 - 82,066,511) 85 82
Additional paid-in capital 456,249 434,839
Accumulated deficit (336,071) (293,069)
Total Stockholders’ Equity 120,263 141,852
Total Liabilities and Stockholders’ Equity $ 135,567 $ 154,386